Skip to Main Content
Awards 2022

Lakes BioScience site in Ulverston gets the green light

PLANS to build a £350m biomanufacturing plant to produce modern medicines have taken a major step forward.

Lakes BioScience, formed from a team of UK industry experts, has been granted planning permission to start work on the site at Ulverston.

The proposals will create 250 high-value, high-tech jobs at a state-of-the-art factory producing monoclonal antibodies.

Read full NW Mail article here